From the American Epicenter: Coronavirus Disease 2019 in Patients with Inflammatory Bowel Disease in the New York City Metropolitan Area-Reference-Cited by-同舟云学术

From the American Epicenter: Coronavirus Disease 2019 in Patients with Inflammatory Bowel Disease in the New York City Metropolitan Area

Published:2020-06-24 Issue:5 Volume:27 Page:662-666
ISSN:1078-0998
Container-title:Inflammatory Bowel Diseases
language:en
Short-container-title:

Author:

Axelrad Jordan E¹^ORCID,Malter Lisa¹,Hong Simon¹,Chang Shannon¹,Bosworth Brian¹,Hudesman David¹

Affiliation:

1. Inflammatory Bowel Disease Center at NYU Langone Health, Division of Gastroenterology and Hepatology, Department of Medicine, NYU Grossman School of Medicine, New York, NY

Abstract

Abstract Background We aimed to characterize patients with inflammatory bowel disease (IBD) and novel coronavirus disease 2019 (COVID-19). Methods We performed a case series of patients with IBD and confirmed or highly suspected COVID-19 to assess rates of severe outcomes. Results We identified 83 patients with IBD with confirmed (54%) or highly suspected (46%) COVID-19. The overall hospitalization rate was 6%, generally comprising patients with active Crohn’s disease or older men with comorbidities, and 1 patient expired. Discussion In this series of patients with IBD, severe outcomes of COVID-19 were rare and comparable to similarly aged individuals in the general population.

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,Immunology and Allergy

Link

http://academic.oup.com/ibdjournal/article-pdf/27/5/662/37064720/izaa162.pdf

Reference9 articles.

1. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding;Lu;Lancet.,2020

2. Clinical characteristics of coronavirus disease 2019 in China;Guan;N Engl J Med.,2020

3. Management of patients with Crohn’s disease and ulcerative colitis during the COVID-19 pandemic: results of an international meeting;Rubin;Gastroenterology.,2020

4. AGA clinical practice update on management of inflammatory bowel disease during the COVID-19 pandemic: expert commentary;Rubin;Gastroenterology.,2020

5. COVID-19: consider cytokine storm syndromes and immunosuppression;Mehta;Lancet.,2020

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID‐19 susceptibility and clinical outcomes in inflammatory bowel disease: An updated systematic review and meta‐analysis;Reviews in Medical Virology;2022-12-11

2. Inflammatory bowel disease and COVID-19 outcomes: a meta-analysis;Scientific Reports;2022-12-09

3. Risk of adverse outcomes in inflammatory bowel disease patients infected with SARS-CoV-2: a systematic review and meta-analysis;International Journal of Colorectal Disease;2022-10-22

4. Crohn's Disease of the Elderly;Gastroenterology Clinics of North America;2022-06

5. Outcomes of COVID-19 in Patients with Inflammatory Bowel Disease: A Tertiary Center Experience;Mediterranean Journal of Infection Microbes and Antimicrobials;2022-04-12